Magdalini Migkou

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

Meletios Α. Dimopoulos, Efstathios Kastritis, Christina Bamia et al. · Annals of Oncology · 2008 · 437 citations · Full text

Bone Disease, Zoledronic Acid, Bone Health +7

Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone

Efstathios Kastritis, Savvas Toumanidis, Constantinos Pamboukas et al. · Haematologica · 2007 · 190 citations · Full text

Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease

Efstathios Kastritis, Evangelos Terpos, Lia A. Moulopoulos et al. · Leukemia · 2012 · 158 citations

Hematological Malignancy, Asymptomatic Myeloma, Health Sciences +12

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment

Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos et al. · Blood Cancer Journal · 2021 · 126 citations · Full text

Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies

Meletios Α. Dimopoulos, Efstathios Kastritis, D. Christoulas et al. · Leukemia · 2010 · 116 citations

Hematological Malignancy, Hematology, Myeloid Neoplasia +6